Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee. (Q48076664)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 May 2014

Language	Label	Description	Also known as
English	Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee.	scientific article published on 12 May 2014

Statements

scholarly article

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24821616

Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee. (English)

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24821616

Séverine Vermeire

12

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24821616

Jean-Frédéric Colombel

11

object named as

Jean-Frederic Colombel

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24821616

Anne M. Griffiths

4

object named as

Anne Griffiths

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24821616

author name string

Frank M Ruemmele

1

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24821616

Jeffrey S Hyams

2

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24821616

Anthony Otley

3

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24821616

Kaija-Leena Kolho

5

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24821616

Jorge Amil Dias

6

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24821616

Arie Levine

7

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24821616

Johanna C Escher

8

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24821616

Jan Taminiau

9

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24821616

Gabor Veres

10

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24821616

David C Wilson

13

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24821616

Dan Turner

14

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24821616

language of work or name

0 references

publication date

12 May 2014

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24821616

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24821616

64

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24821616

438-446

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24821616

3

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24821616

Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Off-label use of medicine in pediatrics: focus on gastrointestinal diseases

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Mucosal healing in patients with ulcerative colitis during a course of selective leukocytapheresis therapy: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Mucosal healing in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

A comparative contrast of clinimetric and psychometric methods for constructing indexes and rating scales

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

"Clinical Judgment" revisited: the distraction of quantitative models.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Design issues and outcomes in IBD clinical trials

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Ethical considerations in conducting pediatric research

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Role of fecal calprotectin testing to predict relapse in teenagers with inflammatory bowel disease who report full disease control.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Fecal calprotectin and clinical disease activity in pediatric ulcerative colitis

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Serial fecal calprotectin changes in children with Crohn's disease on treatment with exclusive enteral nutrition: associations with disease activity, treatment response, and prediction of a clinical relapse

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Development of a quality-of-life index for pediatric inflammatory bowel disease: dealing with differences related to age and IBD type

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

The IMPACT Questionnaire: A Valid Measure of Health-Related Quality of Life in Pediatric Inflammatory Bowel Disease

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Measuring quality of life in pediatric patients with inflammatory bowel disease: psychometric and clinical characteristics

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Validation of an instrument to measure quality of life in British children with inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Disease activity, behavioral dysfunction, and health-related quality of life in adolescents with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

A review of activity indices and end points for clinical trials in children with Crohn's disease

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Differences in the management of pediatric and adult onset ulcerative colitis--lessons from the joint ECCO and ESPGHAN consensus guidelines for the management of pediatric ulcerative colitis

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Does clinical response correlate with mucosal healing in patients with Crohn's disease of the small bowel? A prospective, case-series study using wireless capsule endoscopy

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Impact of capsule endoscopy on management of inflammatory bowel disease: a single tertiary care center experience

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Endoscopic evaluation of Crohn's disease activity: comparison of the CDEIS and the SES-CD.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

European evidence based consensus for endoscopy in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Appraisal of the pediatric Crohn's disease activity index on four prospectively collected datasets: recommended cutoff values and clinimetric properties

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Is an abbreviated Pediatric Crohn's Disease Activity Index better than the original?

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Short pediatric Crohn's disease activity index for quality improvement and observational research

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Mathematical weighting of the pediatric Crohn's disease activity index (PCDAI) and comparison with its other short versions.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Small-bowel MRI in children and young adults with Crohn disease: retrospective head-to-head comparison of contrast-enhanced and diffusion-weighted MRI.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Magnetization transfer for the assessment of bowel fibrosis in patients with Crohn's disease: initial experience

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Perianal Crohn disease: evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Systematic review: MRI enterography for assessment of small bowel involvement in paediatric Crohn's disease.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Development of the Crohn's disease digestive damage score, the Lémann score

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

The diagnostic value of small bowel wall vascularity after sulfur hexafluoride-filled microbubble injection in patients with Crohn's disease. Correlation with the therapeutic effectiveness of specific anti-inflammatory treatment.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Abdominal sonographic changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's Disease.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

The Saskatchewan Pediatric Bone Mineral Accrual Study: bone mineral acquisition during the growing years

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Severe paediatric ulcerative colitis: incidence, outcomes and optimal timing for second-line therapy.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Fecal osteoprotegerin may guide the introduction of second-line therapy in hospitalized children with ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Faecal calprotectin, lactoferrin, M2-pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and monitoring response.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

The minimal detectable change cannot reliably replace the minimal important difference.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

A Comparison of Oral Prednisolone Given as Single or Multiple Daily Doses for Active Proctocolitis

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Correlation Between the Endoscopic and Histologic Score in Assessing the Activity of Ulcerative Colitis

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Prognostic Value of Serologic and Histologic Markers on Clinical Relapse in Ulcerative Colitis Patients With Mucosal Healing

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Are Colonoscopy and Bowel Ultrasound Useful for Assessing Response to Short-Term Therapy and Predicting Disease Outcome of Moderate-to-Severe Forms of Ulcerative Colitis?: A Prospective Study

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-307008

21 January 2018

Identifiers

10.1136/GUTJNL-2014-307008

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24821616

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24821616

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48076664&oldid=1569412173"